DK3423082T3 - Liraglutid ved kardiovaskulære tilstande - Google Patents
Liraglutid ved kardiovaskulære tilstande Download PDFInfo
- Publication number
- DK3423082T3 DK3423082T3 DK17710160.7T DK17710160T DK3423082T3 DK 3423082 T3 DK3423082 T3 DK 3423082T3 DK 17710160 T DK17710160 T DK 17710160T DK 3423082 T3 DK3423082 T3 DK 3423082T3
- Authority
- DK
- Denmark
- Prior art keywords
- liraglutid
- cardiovascular conditions
- cardiovascular
- conditions
- Prior art date
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16158739 | 2016-03-04 | ||
EP16173917 | 2016-06-10 | ||
EP16001329 | 2016-06-13 | ||
US15/401,651 US9968659B2 (en) | 2016-03-04 | 2017-01-09 | Liraglutide in cardiovascular conditions |
PCT/EP2017/054990 WO2017149112A1 (en) | 2016-03-04 | 2017-03-03 | Liraglutide in cardiovascular conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
DK3423082T3 true DK3423082T3 (da) | 2021-10-11 |
DK3423082T5 DK3423082T5 (da) | 2023-02-06 |
Family
ID=59723004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17710160.7T DK3423082T5 (da) | 2016-03-04 | 2017-03-03 | Liraglutid ved kardiovaskulære tilstande |
Country Status (24)
Country | Link |
---|---|
US (2) | US9968659B2 (da) |
EP (1) | EP3423082B1 (da) |
JP (1) | JP6940512B2 (da) |
KR (1) | KR102417455B1 (da) |
CN (2) | CN116327897A (da) |
AU (2) | AU2017225841A1 (da) |
BR (1) | BR112018067344A2 (da) |
CA (1) | CA3013532C (da) |
CL (1) | CL2018002515A1 (da) |
DK (1) | DK3423082T5 (da) |
ES (1) | ES2893755T3 (da) |
HR (1) | HRP20211492T1 (da) |
HU (1) | HUE055844T2 (da) |
IL (1) | IL261169B (da) |
MA (1) | MA43704A (da) |
MX (1) | MX2018010097A (da) |
MY (1) | MY195657A (da) |
PH (1) | PH12018501844A1 (da) |
PL (1) | PL3423082T3 (da) |
RS (1) | RS62501B1 (da) |
RU (1) | RU2745604C2 (da) |
SI (1) | SI3423082T1 (da) |
WO (1) | WO2017149112A1 (da) |
ZA (1) | ZA201805538B (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9968659B2 (en) | 2016-03-04 | 2018-05-15 | Novo Nordisk A/S | Liraglutide in cardiovascular conditions |
CA3177693A1 (en) | 2019-04-05 | 2020-10-05 | Eli Lilly And Company | Therapeutic uses of dulaglutide |
CN117320755A (zh) * | 2020-12-16 | 2023-12-29 | 香港中文大学 | 一种逆转衰老性脑功能衰退的方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5808203A (en) | 1997-05-12 | 1998-09-15 | Medrad, Inc. | Fluid pressure measurement devices |
EP1494704A1 (en) * | 2002-04-04 | 2005-01-12 | Novo Nordisk A/S | Glp-1 agonist and cardiovascular complications |
ES2727854T3 (es) * | 2003-11-20 | 2019-10-21 | Novo Nordisk As | Formulaciones de péptidos que contienen propilenglicol que son óptimas para la producción y para su uso en dispositivos de inyección |
CN101056650A (zh) * | 2004-11-12 | 2007-10-17 | 诺和诺德公司 | 促胰岛素肽的稳定制剂 |
ES2672770T3 (es) * | 2007-09-05 | 2018-06-18 | Novo Nordisk A/S | Derivados del péptido-1 similar al glucagón y su uso farmacéutico |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
AR075204A1 (es) | 2009-01-29 | 2011-03-16 | Boehringer Ingelheim Int | Inhibidores de dpp-4 y composiciones farmaceuticas que los comprenden, utiles para tratar enfermedades metabolicas en pacientes pediatricos, particularmente diabetes mellitus tipo 2 |
EP2411005A1 (en) | 2009-03-27 | 2012-02-01 | Bristol-Myers Squibb Company | Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors |
JP2013525491A (ja) | 2010-05-04 | 2013-06-20 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 心血管障害を治療または予防し心血管保護を提供する方法 |
MX2012014247A (es) | 2010-06-24 | 2013-01-18 | Boehringer Ingelheim Int | Terapia para la diabetes. |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
US20130172244A1 (en) | 2011-12-29 | 2013-07-04 | Thomas Klein | Subcutaneous therapeutic use of dpp-4 inhibitor |
JP6218811B2 (ja) | 2012-05-14 | 2017-10-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Sirs及び/又は敗血症の治療に用いるdpp−4阻害薬としてのキサンチン誘導体 |
JP6224084B2 (ja) | 2012-05-14 | 2017-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糸球体上皮細胞関連障害及び/又はネフローゼ症候群の治療に用いるdpp−4阻害薬としてのキサンチン誘導体 |
JP6374862B2 (ja) | 2012-05-24 | 2018-08-15 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 自己免疫性糖尿病、特に、ladaの治療に使用するためのdpp−4阻害剤としてのキサンチン誘導体 |
CN103893744B (zh) * | 2012-12-24 | 2017-12-19 | 杭州九源基因工程有限公司 | 一种治疗糖尿病的药物制剂及其制备方法 |
MX2015011466A (es) | 2013-03-15 | 2016-01-22 | Boehringer Ingelheim Int | Uso de linagliptina en terapia antidiabetica cardio-y renoprotectora. |
US20140371243A1 (en) | 2013-06-14 | 2014-12-18 | Boehringer Ingelheim International Gmbh | Medical use of a dpp-4 inhibitor |
US8969371B1 (en) | 2013-12-06 | 2015-03-03 | Orexigen Therapeutics, Inc. | Compositions and methods for weight loss in at risk patient populations |
WO2015128453A1 (en) | 2014-02-28 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Medical use of a dpp-4 inhibitor |
WO2016019587A1 (en) | 2014-08-08 | 2016-02-11 | Merck Sharp & Dohme Corp. | [7, 6]-fused bicyclic antidiabetic compounds |
US9968659B2 (en) | 2016-03-04 | 2018-05-15 | Novo Nordisk A/S | Liraglutide in cardiovascular conditions |
-
2017
- 2017-01-09 US US15/401,651 patent/US9968659B2/en active Active
- 2017-03-03 ES ES17710160T patent/ES2893755T3/es active Active
- 2017-03-03 BR BR112018067344A patent/BR112018067344A2/pt unknown
- 2017-03-03 CA CA3013532A patent/CA3013532C/en not_active Expired - Fee Related
- 2017-03-03 JP JP2018546477A patent/JP6940512B2/ja active Active
- 2017-03-03 WO PCT/EP2017/054990 patent/WO2017149112A1/en active Application Filing
- 2017-03-03 CN CN202310320736.6A patent/CN116327897A/zh active Pending
- 2017-03-03 HU HUE17710160A patent/HUE055844T2/hu unknown
- 2017-03-03 MX MX2018010097A patent/MX2018010097A/es unknown
- 2017-03-03 EP EP17710160.7A patent/EP3423082B1/en active Active
- 2017-03-03 SI SI201730917T patent/SI3423082T1/sl unknown
- 2017-03-03 HR HRP20211492TT patent/HRP20211492T1/hr unknown
- 2017-03-03 RS RS20211250A patent/RS62501B1/sr unknown
- 2017-03-03 AU AU2017225841A patent/AU2017225841A1/en not_active Abandoned
- 2017-03-03 RU RU2018134061A patent/RU2745604C2/ru active
- 2017-03-03 MA MA043704A patent/MA43704A/fr unknown
- 2017-03-03 DK DK17710160.7T patent/DK3423082T5/da active
- 2017-03-03 CN CN201780015266.5A patent/CN108778317A/zh active Pending
- 2017-03-03 PL PL17710160T patent/PL3423082T3/pl unknown
- 2017-03-03 KR KR1020187026962A patent/KR102417455B1/ko active IP Right Grant
- 2017-03-03 MY MYPI2018702782A patent/MY195657A/en unknown
-
2018
- 2018-04-18 US US15/956,445 patent/US20180236038A1/en not_active Abandoned
- 2018-08-15 IL IL26116918A patent/IL261169B/en unknown
- 2018-08-20 ZA ZA2018/05538A patent/ZA201805538B/en unknown
- 2018-08-30 PH PH12018501844A patent/PH12018501844A1/en unknown
- 2018-09-03 CL CL2018002515A patent/CL2018002515A1/es unknown
-
2024
- 2024-03-26 AU AU2024201937A patent/AU2024201937A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3283625T3 (da) | Nukleasemedieret genomeditering | |
DK3331869T3 (da) | Muscarinagonister | |
DK3305788T3 (da) | Janus-kinase-hæmmer | |
DK3277719T3 (da) | Polypeptider | |
DK3331528T3 (da) | Muskarinagonister | |
DK3310450T3 (da) | Olie-vand-separator | |
DK3331529T3 (da) | Muskarinagonister | |
DK3448416T3 (da) | Semaglutid ved kardiovaskulære tilstande | |
DK3242685T3 (da) | Cxcr4-bindende molekyler | |
DK3270930T3 (da) | Præeklampsi | |
DK3551355T3 (da) | Immobiliseret indsats | |
DK3292136T3 (da) | Penicillin-g-acylaser | |
DE112016001806A5 (de) | Bausatz | |
DK3253755T3 (da) | Hidtil ukendte cyclopropabenzofuranyl-pyridopyrazindioner | |
DE112015006486A5 (de) | Inkubationsrinne | |
DK3318308T3 (da) | Badmintonketsjer | |
DK3274482T3 (da) | Stenborsknop | |
DK3423082T5 (da) | Liraglutid ved kardiovaskulære tilstande | |
DE112016005599A5 (de) | Strahlungsgrill | |
DE112015005898A5 (de) | Gurtschlossbringer | |
DE102015206660A8 (de) | Plattenaufteilanlage | |
DK3334807T3 (da) | Ildtænder | |
DE112016001124A5 (de) | Spannschutz | |
DE102015000551A8 (de) | Rotationszerstäuberturbine | |
FI20166038A (fi) | Puunkantoteline |